Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M
1
and/or M
4
receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.
苯并咪唑啉酮衍
生物化合物,可以增加大脑中
乙酰胆碱的信号传导或作用,并且对M1和/或
M4受体亚型具有高选择性的
肌肽激动剂,以及包含这些化合物的药物组合物,以及使用这些化合物治疗精神病的方法被披露。